RON Receptor Tyrosine Kinase as a Therapeutic Target for Eradication of Triple-Negative Breast Cancer: Efficacy of Anti-Ron ADC Zt/G4-Mmae
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-18-0252
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
American Association for Cancer Research (AACR)